Juvenile dermatomyositis - Open Access .click

Results 81 to 90 of about 267,960 (152)

, 1970
Juvenile idiopathic inflammatory myopathies (JIIM) are rare conditions which are probably autoimmune in nature. Childhood myositis is relatively more homogeneous than adult myositis.
Shahana A Rahman, Tamanna Begum
core +1 more source

International Guideline on the Diagnosis and Management of Pediatric Patients With Hereditary Angioedema

Allergy, Volume 81, Issue 8, Page 2744-2774, August 2026.
ABSTRACT Hereditary angioedema (HAE) with C1 inhibitor deficiency is a rare disease characterized by unpredictable episodes of tissue swelling (angioedema), which, in most cases, occur first under the age of 18 years, and entail a significant burden of disease not only for the patients but also for their families.
Henriette Farkas +128 more
wiley +1 more source

Tissue calcinosis in dermatomyositis - potential role of combination therapy with JAK inhibitors. Case report and literature review

Frontiers in Immunology
Calcinosis is a disabling and difficult-to-treat complication of adult dermatomyositis (DM), juvenile dermatomyositis (JDM), and systemic sclerosis (SSc), for which no standardized therapy is currently available.
Paulina Janiak +3 more
doaj +1 more source

Muscle MRI at the time of questionable disease flares in Juvenile Dermatomyositis (JDM)

Pediatric Rheumatology Online Journal, 2017
Background The course of JDM has improved substantially over the last 70 years with early and aggressive treatments. Yet it remains difficult to detect disease flares as symptoms may be mild; signs of rash and muscle weakness vary widely and are often ...
Rabheh Abdul-Aziz +6 more
doaj +1 more source

Facilitating Expedited Drug Approval—the Past, Present, and Future of Clinical Trials for Pediatric Rheumatic Disease

Arthritis Care &Research, Volume 78, Issue 10, Page 1317-1323, October 2026.
Pamela F. Weiss, Hermine I. Brunner
wiley +1 more source

Current recommendations regarding the management of juvenile dermatomyositis [PDF]

, 2019
On the basis of: Enders F.B., Bader-Meunier B., Baildam E. et al. Consensus-based recommendations for themanagement of juvenile dermatomyositis. Ann. Rheum. Dis.
Żuber, Zbigniew; Department of Paediatrics, Andrzej Frycz-Modrzewski Krakow University, Clinical Department of Rheumatology, Paediatrics and Allergology, St. Louis Children’s Hospital in Krakow, Kraków, Poland
core +1 more source

Bisphosphonates in juvenile dermatomyositis with dystrophic calcinosis

, 2015
Objectives. Our primary objective was to retrospectively analyze whether bisphosphonates initiated in combination with immunosuppressive drugs and/or intravenous immunoglobulin (IVIG) resulted in a radiological and clinical improvement of dystrophic ...
TOPALOĞLU, REZAN +3 more
core +1 more source

Sodium thiosulfate for the treatment of calcinosis secondary to juvenile dermatomyositis

, 2014
We report the successful use of sodium thiosulfate in a patient with juvenile dermatomyositis complicated by ulcerative skin disease and progressive calcinosis.
Pagnini, I. +7 more
core +3 more sources

Panniculitis in Anti-MDA-5 Positive Juvenile Dermatomyositis: A Case Report

Journal of Nepal Medical Association
Panniculitis is a rare clinical finding in dermatomyositis. There are few reported cases in the medical literature. In this report, we describe a 17-year-old male patient with anti-MDA5 positive hypomyopathic dermatomyositis who, eight months after ...
Semra Ayduran +5 more
doaj +1 more source

Case Report - Juvenile dermatomyositis associated with lipodystrophy

, 2004
Lipodystrophy and associated metabolic abnormalities are being increasingly recognized as complications of juvenile dermatomyositis.
N. T. Irene, B. Parveen, O. H. Hema, V. Rajagopalan
core

dermatomyositis
calcinosis
children

myositis